Transition from Clinical Trials into RWE in Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis

Introduction

Real-World updates about the management of Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis

Objectives

Communicate Ixekizumab and Baricitinib value proposition in a speaker program setting in order to communicate what the product may mean to persons living with Rheumatoid Arthritis, Psoriatic Arthritis or Psoriasis

This Course For :

Physician ( Dermatology , Internal Medicine , Rheumatology )
Resident / Fellow ( Dermatology , Internal Medicine , Rheumatology )

Speaker

Provided by :

Price

Course Fee

FREE

FREE
See Registration Policies, Cancellations & Refunds

Contact Information

Organization : Virtual Medical Academy
Phone : 920008161
Email : [email protected]

  • 02 Jul 2025    To    02 Jul 2025
  • 09:30 PM  To  11:00 PM
  • Certificate Available
  • Online
  • 58
  Add to Calendar 07/02/2025 09:30 PM 07/02/2025 11:00 PM Asia/ Riyadh Transition from Clinical Trials into RWE in Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Transition from Clinical Trials into RWE in Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis https://medicalacademy.org/portal/event/view/2409
Transition from Clinical Trials into RWE in Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis